-
Mashup Score: 09th Annual Congress of the European Society for Translational Medicine (EUSTM-2022) 3-5 October, 2022 (Virtual Congress) - 2 year(s) ago
From Biology to Patients Care
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1ASCO 2021: Best Lung Cancer IO Data - 3 year(s) ago
Pooled analysis supports chemo + immunotherapy for patients with PD-L1 1%-49%; immunosuppressants for adverse effects of immunotherapy; and AI predicts outcomes better than pathologic exam.
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Part 2 Highlight from #ASC021 lung cancer #immunotherapeutics https://t.co/5QI1BbAunO 🎥 https://t.co/cjwYqM8D3U
-
-
Mashup Score: 4
The registration system will be available by mid-August
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#MAP2020 day 2 starting at 12:00 CEST: 📣Keynote address: M. Barbacid 📣#Biomarkers for #immunotherapeutics 📣New technologies for therapeutic targeting 📣#Pancreaticcancers 📣In-situ tissue interpretation Registration 👉https://t.co/aLXNG5itXl @GroupeUNICANCER @CRUKresearch https://t.co/vfZdCE94KC
-
-
Mashup Score: 0Prion Protein Antibodies Found to Be Naturally Occurring - 4 year(s) ago
Antibodies targeting the normal version of the prion protein have been found in humans no history of associated transmissible spongiform encephalopathies
Categories: Future of Medicine, Latest HeadlinesTweet-
Findings from a new study shows that potential #immunotherapeutics could be created to help treat prion disorders like Creutzfeldt-Jakob disease. Read more: https://t.co/8StH0QVjdJ https://t.co/nM6IWSx5P5
-
Honored to speak at this ongoing event on #chemotherapy & #immunotherapy for #bladdercancer with colleagues @MattGalsky @shilpaonc - Please check this great line-up of lectures at this all encompassing virtual #immunotherapeutics conference https://t.co/HVVvXsBZN2 #EUSTM-2022